Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Large-Area Epitaxial Monolayer MoS2.
Dumcenco D, Ovchinnikov D, Marinov K, Lazić P, Gibertini M, Marzari N, Lopez Sanchez O, Kung YC, Krasnozhon D, Chen MW, Bertolazzi S, Gillet P, Fontcuberta i Morral A, Radenovic A, Kis A. Dumcenco D, et al. Among authors: krasnozhon d. ACS Nano. 2015 Apr 28;9(4):4611-20. doi: 10.1021/acsnano.5b01281. Epub 2015 Apr 6. ACS Nano. 2015. PMID: 25843548 Free PMC article.
Electrochemical Reaction in Single Layer MoS2: Nanopores Opened Atom by Atom.
Feng J, Liu K, Graf M, Lihter M, Bulushev RD, Dumcenco D, Alexander DT, Krasnozhon D, Vuletic T, Kis A, Radenovic A. Feng J, et al. Among authors: krasnozhon d. Nano Lett. 2015 May 13;15(5):3431-8. doi: 10.1021/acs.nanolett.5b00768. Epub 2015 May 4. Nano Lett. 2015. PMID: 25928894
MoS2 transistors operating at gigahertz frequencies.
Krasnozhon D, Lembke D, Nyffeler C, Leblebici Y, Kis A. Krasnozhon D, et al. Nano Lett. 2014 Oct 8;14(10):5905-11. doi: 10.1021/nl5028638. Epub 2014 Sep 22. Nano Lett. 2014. PMID: 25243885
Vacuum ultraviolet excitation luminescence spectroscopy of few-layered MoS2.
Pankratov V, Hoszowska J, Dousse JC, Huttula M, Kis A, Krasnozhon D, Zhang M, Cao W. Pankratov V, et al. Among authors: krasnozhon d. J Phys Condens Matter. 2016 Jan 13;28(1):015301. doi: 10.1088/0953-8984/28/1/015301. Epub 2015 Dec 9. J Phys Condens Matter. 2016. PMID: 26648394
Efficacy, Safety, Pharmacokinetics, and Immunogenicity of DRL-Trastuzumab Versus Herceptin in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Randomized Controlled Trial.
Reddy N, Reddy P, Ranpura A, Maharaj N, Arora R, Mamillapalli G, Adhav AS, Diwan AK, Manikhas A, Krasnozhon D. Reddy N, et al. Among authors: krasnozhon d. JCO Glob Oncol. 2024 Jan;10:e2200328. doi: 10.1200/GO.22.00328. JCO Glob Oncol. 2024. PMID: 38237093 Free PMC article. Clinical Trial.
Efbemalenograstim alfa not inferior to pegfilgrastim in providing neutrophil support in women with breast cancer undergoing myelotoxic chemotherapy: results of a phase 2 randomized, multicenter, open-label trial.
Glaspy J, Bondarenko I, Krasnozhon D, Rutty D, Chen J, Fu Y, Wang S, Hou Q, Li S. Glaspy J, et al. Among authors: krasnozhon d. Support Care Cancer. 2024 Jan 9;32(2):91. doi: 10.1007/s00520-023-08260-x. Support Care Cancer. 2024. PMID: 38194162 Free PMC article. Clinical Trial.
Comparison of EP2006, a filgrastim biosimilar, to the reference: a phase III, randomized, double-blind clinical study in the prevention of severe neutropenia in patients with breast cancer receiving myelosuppressive chemotherapy.
Blackwell K, Semiglazov V, Krasnozhon D, Davidenko I, Nelyubina L, Nakov R, Stiegler G, Singh P, Schwebig A, Kramer S, Harbeck N. Blackwell K, et al. Among authors: krasnozhon d. Ann Oncol. 2015 Sep;26(9):1948-1953. doi: 10.1093/annonc/mdv281. Epub 2015 Jun 28. Ann Oncol. 2015. PMID: 26122726 Free PMC article. Clinical Trial.
18 results